The Amino Company

The Amino Company is a life sciences firm that specializes in the development of patented, clinically-validated amino acid formulations designed to treat specific health conditions and promote longevity. The company's products are based on over 40 years of research and significant NIH funding led by co-founder Dr. Robert Wolfe at the University of Texas Medical Branch. Their proprietary platform identifies precise ratios of essential amino acids that optimize metabolic pathways, such as muscle protein synthesis and liver lipid metabolism. The Amino Company offers a range of products targeting indications including sarcopenia, non-alcoholic fatty liver disease, and post-surgical recovery. By utilizing pharmaceutical-grade ingredients and rigorous clinical testing, the company aims to bridge the gap between traditional supplements and medical nutrition. Their business model focuses on direct-to-consumer sales of evidence-based nutritional interventions.